The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness
Background The poor physical health of people with mental illness is a multifaceted,
transdiagnostic, and global problem. People with mental illness have an increased risk of …
transdiagnostic, and global problem. People with mental illness have an increased risk of …
The association between first-episode psychosis and abnormal glycaemic control: systematic review and meta-analysis
Background Schizophrenia might share intrinsic inflammatory disease pathways with type 2
diabetes. We aimed to assess whether first-episode psychosis, which could be described as …
diabetes. We aimed to assess whether first-episode psychosis, which could be described as …
Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis
Background Most antipsychotics are associated with weight gain and other metabolic
complications. Several randomized trials have shown metformin to be effective, but this still …
complications. Several randomized trials have shown metformin to be effective, but this still …
Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis
Background The extent of metabolic and lipid changes in first-episode psychosis (FEP) is
unclear. Aims To investigate whether individuals with FEP and no or minimal antipsychotic …
unclear. Aims To investigate whether individuals with FEP and no or minimal antipsychotic …
Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management
A Ventriglio, A Gentile, E Stella, A Bellomo - Frontiers in neuroscience, 2015 - frontiersin.org
Patients affected by psychotic disorders are more likely to develop high rates of co-
morbidities, such as obesity, type 2 diabetes, dyslipidemias, hypertension, metabolic …
morbidities, such as obesity, type 2 diabetes, dyslipidemias, hypertension, metabolic …
A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia
Metabolic syndrome (MetS) is a cluster of factors that increases the risk of cardiovascular
disease (CVD), one of the leading causes of mortality in patients with schizophrenia …
disease (CVD), one of the leading causes of mortality in patients with schizophrenia …
Disentangling genetic risks for metabolic syndrome
A quarter of the world's population is estimated to meet the criteria for metabolic syndrome
(MetS), a cluster of cardiometabolic risk factors that promote development of coronary artery …
(MetS), a cluster of cardiometabolic risk factors that promote development of coronary artery …
The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed-methods systematic …
D Sud, E Laughton, R McAskill, E Bradley… - Systematic reviews, 2021 - Springer
Background Individuals with severe mental illness, eg schizophrenia have up to a 20%
shortened life expectancy compared to the general population. Cardiovascular disease, due …
shortened life expectancy compared to the general population. Cardiovascular disease, due …
[HTML][HTML] Accelerated aging in schizophrenia patients: the potential role of oxidative stress
OO Okusaga - Aging and disease, 2014 - ncbi.nlm.nih.gov
Several lines of evidence suggest that schizophrenia, a severe mental illness characterized
by delusions, hallucinations and thought disorder is associated with accelerated aging. The …
by delusions, hallucinations and thought disorder is associated with accelerated aging. The …
Systematic review of racial disparities in clozapine prescribing
JC Williams, J Harowitz, J Glover, C Tek… - Schizophrenia Research, 2020 - Elsevier
Objective To conduct a systematic review of published evidence on clozapine prescribing
disparities across racial and ethnic categories, estimate the size of these disparities, and …
disparities across racial and ethnic categories, estimate the size of these disparities, and …